Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 1
2008 2
2009 6
2010 3
2011 8
2012 5
2013 7
2014 9
2015 10
2016 15
2017 14
2018 22
2019 14
2020 15
2021 15
2022 22
2023 20
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
Mei H, Liu X, Li Y, Zhou H, Feng Y, Gao G, Cheng P, Huang R, Yang L, Hu J, Hou M, Yao Y, Liu L, Wang Y, Wu D, Zhang L, Zheng C, Shen X, Hu Q, Liu J, Jin J, Luo J, Zeng Y, Gao S, Zhang X, Zhou X, Shi Q, Xia R, Xie X, Jiang Z, Gao L, Bai Y, Li Y, Xiong J, Li R, Zou J, Niu T, Yang R, Hu Y. Mei H, et al. Among authors: zeng y. J Hematol Oncol. 2021 Feb 25;14(1):37. doi: 10.1186/s13045-021-01047-9. J Hematol Oncol. 2021. PMID: 33632264 Free PMC article. Clinical Trial.
Hypoxia-activated prodrugs and redox-responsive nanocarriers.
Zeng Y, Ma J, Zhan Y, Xu X, Zeng Q, Liang J, Chen X. Zeng Y, et al. Int J Nanomedicine. 2018 Oct 18;13:6551-6574. doi: 10.2147/IJN.S173431. eCollection 2018. Int J Nanomedicine. 2018. PMID: 30425475 Free PMC article. Review.
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Yang S, Zhang X, Gale RP, Du X, Chen CY, Weng JY, Huang J, Li F, Zeng Y, Xiao Z, Hu JD, Yang LJ, Liu ZG, Li GH, Sun XL, Yang W, Feng R, Han YQ, Jing Y, Xu N, Liu XL, Liu ZF, Wang XD, Wu SX, Liang R, Zhang YL, Yang YF, Zhu HL, Pan L, Meng L, Zhao YH, Yi H, Liu YL, Zhang WH, Zheng YJ, Zhou ZP, Chen SN, Qiu HY, Li WM, Jia ZL, Bai YL, Lin LE, Liu BC, Liu CS, Luo JM, Meng JX, Sun ZQ, Zhang YQ, Huang XJ, Jiang Q. Yang S, et al. Among authors: zeng y. Am J Hematol. 2023 Jul;98(7):E183-E186. doi: 10.1002/ajh.26943. Epub 2023 May 2. Am J Hematol. 2023. PMID: 37128776 No abstract available.
Functional probes for cardiovascular molecular imaging.
Zeng Y, Zhu J, Wang J, Parasuraman P, Busi S, Nauli SM, Wáng YXJ, Pala R, Liu G. Zeng Y, et al. Quant Imaging Med Surg. 2018 Sep;8(8):838-852. doi: 10.21037/qims.2018.09.19. Quant Imaging Med Surg. 2018. PMID: 30306063 Free PMC article. Review.
Erratum.
Zeng Y. Zeng Y. Exp Lung Res. 2018 Feb;44(1):62. doi: 10.1080/01902148.2017.1422369. Epub 2018 Jan 26. Exp Lung Res. 2018. PMID: 29373054 No abstract available.
Imaging Agents in Targeting Tumor Hypoxia.
Zeng Y, Ma J, Zhang S, Wu D. Zeng Y, et al. Curr Med Chem. 2016;23(17):1775-800. doi: 10.2174/0929867323666160321122023. Curr Med Chem. 2016. PMID: 26997152 Review.
171 results